Across TCGA pan-cancer cohorts, CPSF1P2 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of CPSF1P2’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where CPSF1P2 RNA is repressed in tumor relative to normal tissue. In most cancer types CPSF1P2 is over-expressed in tumor, although a few such as BRCA show the opposite, repressed pattern.

BRCA and KIRC are the cancer types where CPSF1P2 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CPSF1P2 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	All	All	−0.010	.013	6	view →
KIRC	Male	All	+0.023	.048	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: CPSF1P2 RNA expression & survival · all CPSF1P2 data types